LungLife AI, Inc. (LLAI.L)

GBp 9.5

(0.0%)

EBITDA Summary of LungLife AI, Inc.

LungLife AI, Inc.'s latest annual EBITDA in 2023 was -5.11 Million USD , up 29.04% from previous year.
LungLife AI, Inc.'s latest quarterly EBITDA in 2024 Q2 was -884 Thousand USD , down 0.0% from previous quarter.
LungLife AI, Inc. reported an annual EBITDA of -7.26 Million USD in 2022, down -42.31% from previous year.
LungLife AI, Inc. reported an annual EBITDA of -6.68 Million USD in 2021, down -35.08% from previous year.
LungLife AI, Inc. reported a quarterly EBITDA of -884 Thousand USD for 2024 Q1, up 31.84% from previous quarter.
LungLife AI, Inc. reported a quarterly EBITDA of -1.29 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of LungLife AI, Inc. (2023 - 2018)

Historical Annual EBITDA of LungLife AI, Inc. (2023 - 2018)

Year	EBITDA	EBITDA Growth
2023	-5.11 Million USD	29.04%
2022	-7.26 Million USD	-42.31%
2021	-6.68 Million USD	-35.08%
2020	-3.77 Million USD	-21.53%
2019	-3.1 Million USD	-61.45%
2018	-1.92 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-884 Thousand USD	0.0%
2024 Q1	-884 Thousand USD	31.84%
2023 Q4	-1.29 Million USD	0.0%
2023 FY	- USD	29.04%
2023 Q3	-1.29 Million USD	6.82%
2023 Q2	-1.39 Million USD	0.0%
2023 Q1	-1.39 Million USD	11.42%
2022 Q2	-2.15 Million USD	0.0%
2022 Q1	-2.15 Million USD	-20.68%
2022 Q3	-1.57 Million USD	27.11%
2022 FY	- USD	-42.31%
2022 Q4	-1.57 Million USD	0.0%
2021 FY	- USD	-35.08%
2021 Q2	-1.11 Million USD	0.0%
2021 Q3	-1.78 Million USD	-60.08%
2021 Q4	-1.78 Million USD	0.0%
2021 Q1	-1.11 Million USD	-69.76%
2020 FY	- USD	-21.53%
2020 Q3	-657.4 Thousand USD	17.94%
2020 Q1	-801.08 Thousand USD	0.0%
2020 Q4	-657.4 Thousand USD	0.0%
2020 Q2	-801.08 Thousand USD	-0.0%
2019 FY	- USD	-61.45%
2018 FY	- USD	0.0%

Peer EBITDA Comparison of LungLife AI, Inc.

Name	EBITDA	EBITDA Difference